Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2025-12-25 @ 11:21 PM
Study NCT ID:
NCT03410693
Status:
COMPLETED
Last Update Posted:
2022-09-28
First Post:
2018-01-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-19
First Submit QC Date:
None
Study First Post Date:
2018-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-10-13
Results First Submit QC Date:
None
Results First Post Date:
2021-12-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-25
Last Update Post Date:
2022-09-28
Last Update Post Date Type:
ACTUAL